MPWT
BMRN icon

MassMutual Private Wealth & Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Sell
461
-123
-21% -$6.74K ﹤0.01% 1025
2026
Q1 		$33K Buy
584
+61
+12% +$3.56K ﹤0.01% 910
2025
Q4 		$31.1K Buy
523
+71
+16% +$3.87K ﹤0.01% 954
2025
Q3 		$24.5K Buy
452
+95
+27% +$5.43K ﹤0.01% 1037
2025
Q2 		$19.6K Sell
357
-167
-32% -$9.83K ﹤0.01% 1113
2025
Q1 		$37K Buy
524
+218
+71% +$14.7K ﹤0.01% 825
2024
Q4 		$20.1K Buy
306
+192
+168% +$12.9K ﹤0.01% 1005
2024
Q3 		$8.01K Sell
114
-51
-31% -$4.26K ﹤0.01% 1196
2024
Q2 		$13.6K Buy
165
+96
+139% +$7.99K ﹤0.01% 974
2024
Q1 		$6.03K Sell
69
-5
-7% -$448 ﹤0.01% 1208
2023
Q4 		$7.13K Sell
74
-5
-6% -$442 ﹤0.01% 1128
2023
Q3 		$6.99K Sell
79
-2
-2% -$178 ﹤0.01% 1136
2023
Q2 		$7.02K Buy
81
+11
+16% +$1.03K ﹤0.01% 1086
2023
Q1 		$6.81K Hold
70
– – ﹤0.01% 1061
2022
Q4 		$7K Sell
70
-4
-5% -$376 ﹤0.01% 874
2022
Q3 		$6K Buy
74
+50
+208% +$4.45K ﹤0.01% 874
2022
Q2 		$2K Buy
24
+2
+9% +$159 ﹤0.01% 1112
2022
Q1 		$2K Buy
22
+1
+5% +$84 ﹤0.01% 1125
2021
Q4 		$2K Buy
21
+8
+62% +$660 ﹤0.01% 1058
2021
Q3 		$1K Sell
13
-13
-50% -$1.03K ﹤0.01% 1135
2021
Q2 		$2K Buy
26
+13
+100% +$1.03K ﹤0.01% 994
2021
Q1 		$1K Buy
+13
New +$1.06K ﹤0.01% 934
2017
Q2 		– Sell
-20
Closed -$1.76K – 1048
2017
Q1 		$1.76K Buy
+20
New +$1.78K ﹤0.01% 886

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

MassMutual Private Wealth & Trust's BMRN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its BioMarin Pharmaceuticals (BMRN) stake by 21% in Q2 2026, selling an estimated $6.74K and leaving 461 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

MassMutual Private Wealth & Trust first reported a position in BMRN in Q1 2017 and has held it in 23 quarters since. The position peaked at $37K in Q1 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • MassMutual Private Wealth & Trust held 461 shares of BioMarin Pharmaceuticals worth $26.4K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 123 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $6.74K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1025 holding.
  • MassMutual Private Wealth & Trust first reported a position in BioMarin Pharmaceuticals in Q1 2017 and has held it in 23 quarters since.
  • MassMutual Private Wealth & Trust's BioMarin Pharmaceuticals position peaked at $37K in Q1 2025.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.